|
 Partners
 We are team-oriented professionals and our aim is to be the first choice in the industry for licensing and academic collaborations that bring mutual benefits to each party.
We entered into many collaborations with leading academic centers, CRO-s and biotechnology companies to complement our in-house R&D capabilities.
We are always interested in forming new partnerships covering early-stage research, novel compounds or technologies and implementation of clinical trials.
|
 |
 Corporate
News
 Pharmalef
Inc. is starting coloboration in development of new oral delivery platform
offers pharmaceutical companies the ability to extend the shelf life and
stability of medicinal compounds.
Moreover, oral delivery improves patient compliance, improves treatment, reduces
patient inconvenience, and reduces treatment costs.
Our partners have completed proof of concept and development of a proliposomal
formulation for the model drug, calcitonin, which is used in the treatment
of osteoporosis and thyroid cancer.
Clinical trials are expected to begin at a number of centers across the United
States, Canada and European Union.
|
 |
 |
